Schizotypal disorder and cenestho-hypochondriac syndrome (place of sulpiride in the therapy)
The article is devoted to the treatment of patients with schizotypal disorder. Authors tell about their experience with atypical antipsychotics (sulpiride) in the treatment of patients with sluggish schizophrenia.
Main Authors: | M. A. Parpara, A. E. Bobrov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2014-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/570 |
Similar Items
-
Experience in using sulpiride in non-psychotic endogenous depressive-hypochondriacal disorders
by: Nina Arkadyevna Tyuvina, et al.
Published: (2012-03-01) -
Association between mechanisms of psychological adaptation and cognitive functioning violation in patients with schizotypal disorder
by: A. V. Stepanova, et al.
Published: (2018-07-01) -
EXPERIMENTAL STUDY OF SULPIRIDE TOXICITY AT DIFFERENT FORMS OF ITS INTAKE INTO THE BODY
by: Лариса Геннадьевна Горохова, et al.
Published: (2019-12-01) -
News about medicine affect compliance in people with hypochondriac beliefs
by: S. Kumchenko, et al.
Published: (2021-04-01) -
Relationship of cyberchondria to hypochondriac beliefs and internet use
by: S. Kumchenko, et al.
Published: (2021-04-01)